Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 28, 2026PLoS ONEOpen Access

Rifampicin resistance and associated factors of Mycobacterium tuberculosis among pulmonary tuberculosis-suspected patients in the Amhara National Regional State Comprehensive Specialized Hospitals, Ethiopia

View Full Paper
Ask AI
Bookmark
Share

Authors

TDTebelay DilnessaFMFeleke MogesBTBelay Tessema

Discussion

Loading...

Member takes

Overview

Multicenter study assesses rifampicin resistance in tuberculosis-suspected patients, indicating significant public health concerns.

Key Points

  • To assess prevalence and rifampicin resistance patterns of Mycobacterium tuberculosis among suspected pulmonary tuberculosis cases.
  • Multicenter prospective cross-sectional study conducted from April 2023 to May 2025
  • Data collected using semi-structured questionnaires and sputum tests via GeneXpert MTB/RIF
  • Binary logistic regression used to analyze predictors of M. tuberculosis and rifampicin resistance prevalence.
  • Overall prevalence of M. tuberculosis was 5.9% (150/2548 participants)
  • Rifampicin resistance was found in 12.7% (19/150) of MTB-positive cases
  • Prior antibiotic use, HIV-positivity, and alcohol consumption were associated with increased tuberculosis infection.

Cite This Study

Dilnessa et al. (2026) studied this question.

synapsesocial.com/papers/6a40bb1461bb0a67205c6b96https://doi.org/10.1371/journal.pone.0351964
View Full Paper
Ask AI
Bookmark
Share